$RNGE
RANGE IMPACT, INC. Stock $rnge

$rnge Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224032282 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue	$2.172M	$2.350M	$6.878M
YoY Change	-60.19%	-41.23%	159.95%
Cost Of Revenue	$2.565M	$2.499M	$4.995M
YoY Change	-1.28%	-20.76%	198.16%
Gross Profit	-$392.9K	-$148.9K	$1.883M
YoY Change	-113.75%	-117.62%	94.01%
Gross Profit Margin	-18.09%	-6.34%	27.38%
Selling, General & Admin		$697.7K	$1.603M
YoY Change		9.72%	83.03%
% of Gross Profit			85.11%
Research & Development		$157.3K	$104.4K
YoY Change		46.38%	-19.98%
% of Gross Profit			5.55%
Depreciation & Amortization	$317.3K	$638.4K	$711.7K
YoY Change	-15.15%	86.83%	242.8%
% of Gross Profit			37.8%
Operating Expenses	$473.9K	$855.0K	$1.707M
YoY Change	-60.44%	15.02%	69.67%
Operating Profit	-$866.9K	-$1.004M	$124.0K
YoY Change	-152.23%	-1086.55%	-585.17%
Interest Expense	$155.4K	$165.7K	-$259.0K
YoY Change	14.72%	154.87%	902.24%
% of Operating Profit			-208.82%
Other Income/Expense, Net	-$3.873M	-$165.2K
YoY Change	-322.07%	154.13%
Pretax Income	-$4.740M	-$1.169M	-$83.02K
YoY Change	-239.25%	-3280.3%	35.21%
Income Tax	$2.955K	$56.60K
% Of Pretax Income
Net Earnings	-$4.920M	-$1.226M	-$83.02K
YoY Change	-244.54%	-3434.1%	61.52%
Net Earnings / Revenue	-226.57%	-52.16%	-1.21%
Basic Earnings Per Share	-$0.05	-$0.01
Diluted Earnings Per Share	-$0.05	-$0.01
COMMON SHARES
Basic Shares Outstanding	104.7M shares	101.0M shares	89.69M shares
Diluted Shares Outstanding	103.1M shares	101.6M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$123.7K	$2.177M
YoY Change		-65.59%	392.08%
Cash & Equivalents	$244.6K	$123.7K	$2.177M
Short-Term Investments
Other Short-Term Assets		$42.20K	$115.3K
YoY Change		-11.57%	13004.55%
Inventory		$725.4K
Prepaid Expenses	$29.98K	$42.20K	$115.3K
Receivables	$4.134M	$4.389M	$7.185M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$5.105M	$6.655M	$9.725M
YoY Change	25.26%	136.84%	582.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.585M	$12.03M	$13.30M
YoY Change	-63.22%	96.04%	120.03%
Goodwill	$751.4K	$751.4K	$751.4K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$9.980K	$9.980K
YoY Change		-50.05%	12.26%
Total Long-Term Assets	$5.337M	$12.79M	$14.06M
YoY Change	-63.87%	85.16%	106.64%
TOTAL ASSETS
Total Short-Term Assets	$5.105M	$6.655M	$9.725M
Total Long-Term Assets	$5.337M	$12.79M	$14.06M
Total Assets	$10.44M	$19.44M	$23.79M
YoY Change	-44.59%	100.11%	189.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.100M	$2.037M	$3.714M
YoY Change	18.98%	163.54%	1488.49%
Accrued Expenses	$112.1K	$54.40K	$101.3K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$2.200M	$2.400M
YoY Change		83.33%
Long-Term Debt Due	$1.458M	$2.617M	$2.756M
YoY Change	-41.94%	140.24%	108.9%
Total Short-Term Liabilities	$4.770M	$7.059M	$8.971M
YoY Change	-10.6%	130.5%	477.66%
LONG-TERM LIABILITIES
Long-Term Debt	$2.404M	$4.199M	$5.250M
YoY Change	-59.2%	21.43%	40.45%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$2.404M	$4.199M	$5.250M
YoY Change	-59.2%	21.43%	40.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.770M	$7.059M	$8.971M
Total Long-Term Liabilities	$2.404M	$4.199M	$5.250M
Total Liabilities	$7.174M	$11.26M	$14.22M
YoY Change	-36.1%	72.66%	168.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$54.44M	-$49.52M	-$47.08M
YoY Change	15.84%	-1.75%	-6.24%
Common Stock	$57.71M	$57.71M	$56.65M
YoY Change	5.66%	7.66%	6.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.268M	$8.184M	$9.567M
YoY Change
Total Liabilities & Shareholders Equity	$10.44M	$19.44M	$23.79M
YoY Change	-44.59%	100.11%	189.03%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$4.920M	-$1.226M	-$83.02K
YoY Change	-244.54%	-3434.1%	61.52%
Depreciation, Depletion And Amortization	$317.3K	$638.4K	$711.7K
YoY Change	-15.15%	86.83%	242.8%
Cash From Operating Activities		-$550.5K	-$636.1K
YoY Change		-48.75%	1704.99%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$16.28K
YoY Change		-100.0%	-99.64%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00	-$16.28K
YoY Change		-100.0%	-99.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		6.500K	1.803M
YoY Change		-99.48%	-53.66%
NET CHANGE
Cash From Operating Activities		-550.5K	-636.1K
Cash From Investing Activities		0.000	-16.28K
Cash From Financing Activities		6.500K	1.803M
Net Change In Cash		-544.0K	1.151M
YoY Change		-516.72%	-261.04%
FREE CASH FLOW
Cash From Operating Activities		-$550.5K	-$636.1K
Capital Expenditures		$0.00	$16.28K
Free Cash Flow		-$550.5K	-$652.4K
YoY Change		-50.52%	-85.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53832
	dei	Entity Registrant Name EntityRegistrantName	RANGE IMPACT, INC.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
	dei	Entity Address City Or Town EntityAddressCityOrTown	Cleveland
	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44122
	dei	City Area Code CityAreaCode	(216)
	dei	Local Phone Number LocalPhoneNumber	304-6556
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	RNGE
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2200000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2617444	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2755792	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5250027	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5250027	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14221116	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104727189	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101023485	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101023485	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	101023	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	56547804	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47081799	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9567028	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23788144	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001438943
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-3268988
	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Park Avenue
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	104727189	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	6	segment
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment	6156000	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	554900	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	199500	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	6910400	usd
CY2024Q2	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2024Q2	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2024Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	51990	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	35920	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	60970	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11392544	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.47
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	250000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.38
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	23334	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.09
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11619210	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.45
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11394210	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.46
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11619210	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	875480	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11619210	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11394210	shares
	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent		usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2023Q4	us-gaap	Energy Related Inventory Coal EnergyRelatedInventoryCoal		usd
CY2023Q4	us-gaap	Energy Related Inventory EnergyRelatedInventory		usd
CY2024Q2	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P6Y
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments		usd
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments		usd
	RNGE	Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged		shares
	RNGE	Share Based Compensation Arrangements By Share Based Payment Award Options Exchanged In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExchangedInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	RNGE	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercised Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisedPrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross		shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross		shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross		shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross		shares
CY2024Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Document Type DocumentType	10-Q
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2176800	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7185411	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	247310	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	725429	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	42204	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	115324	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9724845	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13301902	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9976	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	12786427	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	14063299	usd
CY2024Q2	us-gaap	Assets Assets	19441520	usd
CY2023Q4	us-gaap	Assets Assets	23788144	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2036868	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3714014	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2400000	usd
CY2024Q2	us-gaap	Deposit Liability Current DepositLiabilityCurrent	150000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	101283	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8971089	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	104727189	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7013154	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5519051	usd
	us-gaap	Gross Profit GrossProfit	1494103	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1361946	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	157278	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	107444	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	288918	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	213621	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	854977	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	743342	usd
	us-gaap	Operating Expenses OperatingExpenses	1930518	usd
	us-gaap	Operating Expenses OperatingExpenses	1575567	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1003906	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	101759	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2060593	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-81464	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	165660	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	64997	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	340918	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	108634	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-165175	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-64997	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-322328	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-108634	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56600	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56600	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2024-11-30
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.01	pure
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	prime rate plus one percent margin
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0950	pure
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1225681	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	36762	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2439521	usd
	us-gaap	Net Income Loss NetIncomeLoss	-190098	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101552586	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101552586	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80519745	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80519745	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101288035	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101288035	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79324917	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79324917	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8357678	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	51990	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1225681	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	8183987	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2712583	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	410000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	35920	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	36762	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3195265	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9567028	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56480	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2439521	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	8183987	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2939443	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2939443	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	410000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	35920	usd
	us-gaap	Net Income Loss NetIncomeLoss	-190098	usd
	us-gaap	Net Income Loss NetIncomeLoss	-190098	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3195265	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3195265	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2439521	usd
	us-gaap	Net Income Loss NetIncomeLoss	-190098	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	56480	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	35920	usd
	RNGE	Depreciation Expense DepreciationExpense	1276872	usd
	RNGE	Depreciation Expense DepreciationExpense	695910	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2796626	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1421296	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1127652	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	725429	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-73121	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	46835	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1677147	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	539084	usd
	RNGE	Increase Decrease In Deposit IncreaseDecreaseInDeposit	-150000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-46881	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	11084	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1663531	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-398399	usd
	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	784515	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-784515	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1000000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	410000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	383202	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1189556	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	893093	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-200000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1200000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-389556	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1100109	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2053087	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-82805	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2176800	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	442369	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	123713	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	359564	usd
	us-gaap	Interest Paid Net InterestPaidNet	251348	usd
	us-gaap	Interest Paid Net InterestPaidNet	108634	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zL7roH7RbBK7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zTmLIYXoPUTi">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2349738	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3998267	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6259631	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7013154	usd
CY2024Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	0	usd
CY2023Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	2100255	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4388785	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7185411	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q2	RNGE	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	1623680	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	1000000	usd
	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	mature between 2025 through 2029
CY2023Q4	RNGE	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	425634	usd
CY2024Q2	RNGE	Estimated Earnings EstimatedEarnings	1192317	usd
CY2023Q4	RNGE	Estimated Earnings EstimatedEarnings	340528	usd
CY2024Q2	RNGE	Revenue Earned On Contracts In Progress RevenueEarnedOnContractsInProgress	2815997	usd
CY2023Q4	RNGE	Revenue Earned On Contracts In Progress RevenueEarnedOnContractsInProgress	766162	usd
CY2024Q2	RNGE	Contract Billings To Date ContractBillingsToDate	1441035	usd
CY2023Q4	RNGE	Contract Billings To Date ContractBillingsToDate	518852	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1374962	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	247310	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	725429	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	725429	usd
CY2024Q2	us-gaap	Energy Related Inventory Coal EnergyRelatedInventoryCoal	725429	usd
CY2024Q2	us-gaap	Energy Related Inventory EnergyRelatedInventory	725429	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3574196	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2297324	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12025030	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13301902	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1276872	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1781573	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14932545	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14705879	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14932545	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14705879	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1225681	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	36762	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2439521	usd
	us-gaap	Net Income Loss NetIncomeLoss	-190098	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101552586	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80519745	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101288035	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79324917	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101552586	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80519745	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101288035	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79324917	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101552586	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80519745	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101288035	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79324917	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2349738	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-148929	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1225681	usd
CY2024Q2	us-gaap	Assets Assets	19441520	usd
CY2024Q2	us-gaap	Depreciation Depreciation	638437	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	165660	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56600	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3998267	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	845101	usd
CY2023Q2	us-gaap	Assets Assets	9715480	usd
CY2023Q2	us-gaap	Depreciation Depreciation	341726	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	64997	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	38289	usd
	us-gaap	Gross Profit GrossProfit	-130075	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2439521	usd
CY2024Q2	us-gaap	Assets Assets	19441520	usd
	us-gaap	Depreciation Depreciation	1276872	usd
	us-gaap	Interest Expense InterestExpense	340918	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56600	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7013154	usd
	us-gaap	Gross Profit GrossProfit	1494103	usd
	us-gaap	Net Income Loss NetIncomeLoss	-190098	usd
CY2023Q2	us-gaap	Assets Assets	9715480	usd
	us-gaap	Depreciation Depreciation	695910	usd
	us-gaap	Interest Expense InterestExpense	108634	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	784515	usd

Files In Submission

Name	View Source	Status
0001493152-24-032282-index-headers.html	Edgar Link	pending
0001493152-24-032282-index.html	Edgar Link	pending
0001493152-24-032282.txt	Edgar Link	pending
0001493152-24-032282-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rnge-20240630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rnge-20240630_cal.xml	Edgar Link	unprocessable
rnge-20240630_def.xml	Edgar Link	unprocessable
rnge-20240630_lab.xml	Edgar Link	unprocessable
rnge-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RNGE
RANGE IMPACT, INC. Stock $rnge

2024 Q3 Form 10-Q Financial Statement

#000149315224032282 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNGE RANGE IMPACT, INC. Stock $rnge

2024 Q3 Form 10-Q Financial Statement

#000149315224032282 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNGE
RANGE IMPACT, INC. Stock $rnge